European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

  1. Zinzani, P.L.
  2. Karlin, L.
  3. Radford, J.
  4. Caballero, D.
  5. Fields, P.
  6. Chamuleau, M.E.D.
  7. D’Amore, F.
  8. Haioun, C.
  9. Thieblemont, C.
  10. González-Barca, E.
  11. Grande García, C.
  12. Johnson, P.W.
  13. Van Imhoff, G.W.
  14. Ng, T.
  15. Dwyer, K.
  16. Morschhauser, F.
Revue:
Haematologica

ISSN: 1592-8721,  0390-6078

Année de publication: 2016

Volumen: 101

Número: 10

Pages: e407-e410

Type: Lettre

DOI: 10.3324/HAEMATOL.2016.146977 GOOGLE SCHOLAR lock_openAccès ouvert editor